Bisphosphonate Use After Estrogen Receptor–Positive Breast Cancer and Risk of Contralateral Breast Cancer

BACKGROUND: A growing body of evidence suggests that nitrogenous bisphosphonates may reduce the risk of developing a first breast cancer and may prevent metastases among breast cancer survivors. However, their impact on risk of second primary contralateral breast cancer is uncertain. METHODS: Within...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Monsees, Genevieve M., Malone, Kathleen E., Tang, Mei-Tzu C., Newcomb, Polly A., Li, Christopher I.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2011
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3232186/
https://ncbi.nlm.nih.gov/pubmed/22021667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djr399
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky